Collins Stewart Comments on Quidel (QDEL) Related to Swine Flu Outbreak
More News related to QDEL
- Stephens Upgrades Quidel (QDEL) to Equalweight
- Quidel (QDEL) Reports Strong Q3 Results
- Quidel Corp. (QDEL) halted; Reporting EPS of $0.50
- Quidel Reports Third Quarter 2009 Results
- Quidel Announces Launch of Their MicroVue(R) C5a EIA Kit for Research Use Only
More News related to Analyst Comments
- Wilshire Enterprises (WOC) Announces Resignation of COO
- Ross Stores (ROST) Restructures Senior Management
- Illinois Tool Works (ITW) Names David B. Smith, Jr. to Board
- Dell (DELL) Appoints Ross Perot Jr. to Board
- Huntington Bancorp. (HBAN) Names David Anderson to EVP and Controller
Collins Stewart made comments on Quidel (Nasdaq: QDEL) related to the swine flu outbreak.
The firm said, "The point-of-care (POC) flu tests sold by Quidel (and its competitors) are able to detect the presence of type A influenza virus, including subtype H1N1. As is seen during the flu season, these POC tests are helpful in assisting physicians to rule out bacteria as the cause for upper respiratory symptoms in a presenting patient. Because the genetic base of this virus is new, there has been no validation of Quidel s test with this type A, subtype H1N1 swine flu virus. What Quidel s test cannot do is confirm that the type A flu virus that has infected a patient is this particular swine flu virus." They said the current situation is likely to create an opportunity for non-seasonal use of Quidel's flu tests.
Shares of Quidel are up 20% this morning on the swine flu news.
Related Categories
Analyst CommentsMomentum Movers
Stocks Mentioned
+0.42Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
